发明名称 ACTIVATABLE FIBRINOLYTIC AND ANTI-THROMBOTIC PROTEINS
摘要 <p>PCT No. PCT/GB90/01911 Sec. 371 Date Jun. 3, 1992 Sec. 102(e) Date Jun. 3, 1992 PCT Filed Dec. 7, 1990 PCT Pub. No. WO91/09125 PCT Pub. Date Jun. 27, 1991.Relatively inactive fusion proteins are activatable by enzymes of the clotting cascade to have fibrinolytic and/or clot formation inhibition activity. For example, a fusion protein comprising two hirudin or streptokinase molecules, linked by a cleavable linkage sequence, may be cleaved to yield anti-thrombotic hirudin or fibrinolytic streptokinase by thrombin or Factor Xa. Fibrinolytic or clot formation inhibition activity is therefore directed to the site of clot formation. Cleavable streptokinase/hirudin heterodimers are claimed.</p>
申请公布号 EP0502968(B1) 申请公布日期 1997.07.23
申请号 EP19910900851 申请日期 1990.12.07
申请人 BRITISH BIOTECH PHARMACEUTICALS LIMITED 发明人 DAWSON, KEITH MARTYN;EDWARDS, RICHARD MARK;FORMAN, JOAN MABEL
分类号 A61K38/46;A61K38/00;A61K38/48;A61K38/55;A61P7/02;C07K7/64;C07K14/00;C07K14/315;C07K14/745;C07K14/81;C07K14/815;C07K19/00;C12N;C12N1/19;C12N1/21;C12N5/10;C12N9/48;C12N9/64;C12N9/68;C12N9/70;C12N9/72;C12N15/09;C12N15/15;C12N15/57;C12N15/62;C12N15/81;C12N15/85;C12P21/02;(IPC1-7):C12N9/68 主分类号 A61K38/46
代理机构 代理人
主权项
地址